
PET Agent Receives FDA Fast Track Designation for mCRPC
The Food and Drug Administration (FDA) has granted a fast track designation for the positron emission tomography (PET) agent 67Cu-SAR-bisPSMA for the treatment of adults with metastatic castration-resistant prostate cancer (mCRPC) previously treated with …